Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Heterogeneity Of Leukemic Stem Cell Capacity Of BCR-ABL+ Long-Term Hematopoietic Stem cells In CML Is Associated With Variability In MPL Expression

Bin Zhang, PhD, Yin Wei Ho, Wei Tong, PhD, Ling Li, PhD, Ravi Bhatia, MD

Blood (2013) 122 (21): 516.

https://doi.org/10.1182/blood.V122.21.516.516

Published: 2013

Journal Articles

Inhibition Of Microenvironmental Interleukin-1 Signaling Enhances TKI-Mediated Targeting Of Chronic Myelogenous Leukemia Stem Cells

Bin Zhang, PhD, Yin Wei Ho, Tessa L. Holyoake, PhD, Ravi Bhatia, MD

Blood (2013) 122 (21): 512.

https://doi.org/10.1182/blood.V122.21.512.512

Published: 2013

Journal Articles

The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents

Cedric Dos Santos, Tinisha McDonald, Yin Wei Ho, Hongjun Liu, Allen Lin, Stephen J. Forman, Ya-Huei Kuo, Ravi Bhatia

Blood (2013) 122 (11): 1900–1913.

https://doi.org/10.1182/blood-2012-11-466425

Published: 2013

Includes: Supplemental data

Journal Articles

Nrf2 Deficiency Leads to Reduced Hematopoietic Stem Cell Self-Renewal and Increased Sensitivity to Genotoxic Stressors Through Impaired P53 Function

Liang Li, PhD, Yin Wei Ho, Ling Li, PhD, Qin Huang, MD, PhD, Min Li, PhD, Stephen J. Forman, MD, Smita Bhatia, MD, MPH, Ravi Bhatia, MD

Blood (2012) 120 (21): 397.

https://doi.org/10.1182/blood.V120.21.397.397

Published: 2012

Journal Articles

Leukemia-Induced Alterations in Bone Marrow Cytokine and Chemokine Levels Contribute to Altered Stem Cell Lodgment and Impairment of Normal Stem Cell Growth in CML

Bin Zhang, Yin Wei Ho, Tessa L. Holyoake, PhD, FRCP, FRCPath, Claudia S Huettner, PhD, Ravi Bhatia, MD

Blood (2011) 118 (21): 962.

https://doi.org/10.1182/blood.V118.21.962.962

Published: 2011

Journal Articles

Nrf2 Deficiency Leads to Altered Hematopoietic Stem Cell Function and Increased Sensitivity to Alkylating Agent Induced Myeloid Dysplasia,

Liang Li, PhD, Yin Wei Ho, Qin Huang, MD, PhD, Min Li, PhD, Stephen J. Forman, MD, Smita Bhatia, MD, MPH, Ravi Bhatia, MD

Blood (2011) 118 (21): 3828.

https://doi.org/10.1182/blood.V118.21.3828.3828

Published: 2011

Journal Articles

Pharmacological Inhibition of the Stress-Related Deacetylase SIRT1 Enhances Eradication of CML stem Cells

Ling Li, PhD, Lisheng Wang, PhD, Liang Li, PhD, Tinisha McDonald, Yin Wei Ho, Tessa L. Holyoake, PhD, FRCP, FRCPath, Wenyong Chen, PhD, Ravi Bhatia, MD

Blood (2011) 118 (21): 448.

https://doi.org/10.1182/blood.V118.21.448.448

Published: 2011

Journal Articles

Inhibition of Chronic Myeloid Leukemia Stem Cells by the Combination of the Hedgehog Pathway Inhibitor LDE225 with Nilotinib

Bin Zhang, David Irvine, Yin Wei Ho, Silvia Buonamici, PhD, Paul Manley, PhD, Tessa L. Holyoake, PhD, FRCP, FRCPath, Mhairi Copland, PhD, BSc, MRCP, FRCPath, Ravi Bhatia, MD

Blood (2010) 116 (21): 514.

https://doi.org/10.1182/blood.V116.21.514.514

Published: 2010

Journal Articles

Altered Niche Interactions of Leukemia Stem Cells In a Chronic Phase Chronic Myelogenous Leukemia (CML) Transgenic Mouse Model.

Bin Zhang, Yin Wei Ho, Qin Huang, M.D., Ph.D., Claudia Huettner, Ravi Bhatia, MD

Blood (2010) 116 (21): 1212.

https://doi.org/10.1182/blood.V116.21.1212.1212

Published: 2010

Journal Articles

Characterization of Leukemia-Initiating Cells in a Transgenic Model of Chronic Phase Chronic Myelogenous Leukemia (CML).

Bin Zhang, MD, PhD, Yin Wei Ho, Sung-UK Lee, PhD, Takahiro Maeda, MD, PhD, Claudia Huettner, PhD, Ravi Bhatia, MD

Blood (2009) 114 (22): 858.

https://doi.org/10.1182/blood.V114.22.858.858

Published: 2009

Journal Articles

Effective Targeting of Quiescent CML Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate.

Bin Zhang, MD, PhD, Adam Campbell Strauss, Su Chu, MD, Yin Wei Ho, David S. Snyder, MD, Claudia Huettner, PhD, Lenny Shultz, Tessa L Holyoake, PhD, Ravi Bhatia, MD

Blood (2009) 114 (22): 190.

https://doi.org/10.1182/blood.V114.22.190.190

Published: 2009

NARROW

Heterogeneity Of Leukemic Stem Cell Capacity Of BCR-ABL+ Long-Term Hematopoietic Stem cells In CML Is Associated With Variability In MPL Expression

Inhibition Of Microenvironmental Interleukin-1 Signaling Enhances TKI-Mediated Targeting Of Chronic Myelogenous Leukemia Stem Cells

The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents

Nrf2 Deficiency Leads to Reduced Hematopoietic Stem Cell Self-Renewal and Increased Sensitivity to Genotoxic Stressors Through Impaired P53 Function

Leukemia-Induced Alterations in Bone Marrow Cytokine and Chemokine Levels Contribute to Altered Stem Cell Lodgment and Impairment of Normal Stem Cell Growth in CML

Nrf2 Deficiency Leads to Altered Hematopoietic Stem Cell Function and Increased Sensitivity to Alkylating Agent Induced Myeloid Dysplasia,

Pharmacological Inhibition of the Stress-Related Deacetylase SIRT1 Enhances Eradication of CML stem Cells

Inhibition of Chronic Myeloid Leukemia Stem Cells by the Combination of the Hedgehog Pathway Inhibitor LDE225 with Nilotinib

Altered Niche Interactions of Leukemia Stem Cells In a Chronic Phase Chronic Myelogenous Leukemia (CML) Transgenic Mouse Model.

Characterization of Leukemia-Initiating Cells in a Transgenic Model of Chronic Phase Chronic Myelogenous Leukemia (CML).

Effective Targeting of Quiescent CML Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only